Skip to main content
Ipsos
  • About us
  • Investors
  • Careers
  • Contact us
Choose your market:
Ireland
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
    • Who we are
    • Our history
    • Key figures
    • Management
    • Values
    • Taking responsibility
    • Privacy & Data Protection
    • Online Data Quality Matters
  • Investors (En)
  • Careers
    • Opportunities at Ipsos
    • Professional vacancies
    • Training & Development
  • Contact us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 54 results matching with your query. Refine by
  • Society

    Patients’ perception and adherence regarding Methotrexate Autoinjectors for Rheumatoid Arthritis

    Rheumatoid arthritis is a chronic, inflammatory joint disease. In developed countries, it affects 0.5% to 1% of the adult population, with a two to three times higher frequency in women compared to men, regardless of age. Currently, no cure exists, however, treatments that are available worldwide can reduce progression of joint damage in up to 90% of patients.

    19 July 2021
  • What a difference a year makes

    Profiling the ‘Digital Doctor’ in 2021

    29 June 2021
  • Society

    Ipsos MRBI/IPHA COVID Vaccine Tracker - June 2021

    Only 4% of people still to decide whether they will get vaccinated for COVID-19, says Ipsos MRBI tracker survey for IPHA

    21 June 2021
  • Society

    Ipsos MRBI/IPHA COVID Vaccine Tracker - May 2021

    Public appetite for COVID-19 vaccine rises to 88%, says Ipsos MRBI tracker survey for IPHA. Just 4% of people would refuse a COVID-19 vaccine as hesitancy trends downwards since the start of the year.

    24 May 2021
  • Society

    Ipsos MRBI/IPHA COVID Vaccine Tracker - April 2021

    Public appetite for COVID-19 vaccine rises to 85%, says Ipsos MRBI tracker survey for IPHA.

    Just 6% of people would refuse a COVID-19 vaccine, a consistent trend since the start of the year.

    26 April 2021
  • Society

    Ipsos MRBI Veracity Index 2021 – Who do we trust?

    Public trust in healthcare professionals remains as strong as ever, while trust in policy makers declines.

    30 March 2021
  • What Worries the World – March 2021

    “What Worries the World?”: One year on, COVID-19 remains the greatest global concern.

    24 March 2021
  • COVID-19 one year on: Global public loses confidence in institutions

    Tracking survey data shows who gained and lost with the public over the past year.

    5 March 2021
  • Society

    Ipsos MRBI/IPHA COVID Vaccine Tracker - February 2021

    Just 6% of people will refuse COVID-19 vaccine, says Ipsos MRBI tracker survey for IPHA

    24 February 2021
  • What Worries the World – February 2021

    Almost two-thirds (64%) of the public across 27 countries say things in their country are heading in the wrong direction. Coronavirus remains the number one concern in our global survey – a place it has occupied for almost a year.

    24 February 2021
Pagination
  • First page 1
  • Previous page <
  • Current page 3
  • Next page >
  • Last page 6

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • News & Events
  • Innovation & Knowledge
    • Corporate
    • New Services
    • Society
  • OUR SOLUTIONS
    • Doctors & Patients
  • Citizens
  • Consumers & Brands
  • Customers & Employees
  • Doctors & Patients
  • Capabilities
  • About us
  • Contact
  • Press
  • Investors
  • Careers
  • JNLR
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal Mentions
  • Privacy and Data Protection
  • Cookie policy
  • Our Alert System